 
    A Chinese bio-pharmaceutical company.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 13, 2017 | Series A | $15M | 3 |  | — | Detail | 
| Jun 26, 2017 | Grant | $225K | 1 |  National Science Foundation | — | Detail | 
| Investor Name | Lead Investor | Funding Round | 
|---|---|---|
|  | Yes | Series A | 
|  | Yes | Series A | 
|  National Science Foundation | Yes | Grant | 
|  JiangSu QianRong Assets Management | — | Series A |